Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Can gastrointestinal allergic or eosinophilic disorders cause peripheral eosinophilia?

Gastrointestinal allergic and eosinophilic disorders can produce peripheral blood eosinophilia driven by gut antigen stimulation and systemic IL-5–mediated bone marrow activation.

PlausibleJune 19, 20266 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Gastrointestinal allergic or eosinophilic disorders can present with peripheral eosinophilia, reflecting gut-driven antigen stimulation.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes that mucosal exposure to food antigens in EGIDs induces a gut-homing Th2 response with high IL-5, which stimulates bone marrow eosinophil production and release, resulting in peripheral eosinophilia. Peripheral eosinophilia is a frequent but variable marker and may not correlate directly with tissue eosinophil density, so normal blood counts do not exclude active gastrointestinal eosinophilic disease.

Verified conclusion

The claim that gastrointestinal allergic or eosinophilic disorders (EGIDs) can present with peripheral eosinophilia reflecting gut-driven antigen stimulation is supported by science. Clinical and mechanistic evidence confirms that localized mucosal exposure to food antigens triggers a systemic immunological cascade resulting in elevated circulating eosinophils.

Clinical evidence and presentation

  • Variable correlation: Peripheral eosinophilia is a frequent but inconsistent clinical feature of EGIDs. It is detected in approximately 70% to 80% of patients with eosinophilic gastroenteritis (EGE).
  • Tissue vs. blood levels: There is a weak direct correlation between the absolute peripheral blood eosinophil count and the density of tissue-level eosinophilic infiltration. Highly symptomatic mucosal disease can exist even in patients with normal peripheral blood eosinophil counts.
  • Predictive value: Marked peripheral blood eosinophilia is more strongly associated with deeper anatomical involvement of the GI wall (such as the muscularis or serosal layers) rather than isolated mucosal disease.

Mechanistic explanations

  • Th2 Polarization: Intestinal dendritic cells sample food antigens in the gut-associated lymphoid tissue (GALT) and present them to naive CD4⁺ T cells, promoting the development of an antigen-specific, gut-homing IL-5-high Th2 response.
  • Systemic Eosinophilopoiesis: Localized mucosal antigen stimulation triggers the systemic release of interleukin-5 (IL-5). This cytokine acts directly on progenitor cells in the bone marrow to stimulate the proliferation, differentiation, maturation, and systemic release of eosinophils into the bloodstream, manifesting as peripheral eosinophilia.
  • Mucosal Homing: Simultaneously, Th2-derived IL-4 and IL-13 stimulate the local production of eotaxins (CCL11, CCL24, CCL26) by the intestinal epithelium. These eotaxins bind CCR3 receptors on the newly released circulating eosinophils, pulling them from the peripheral blood into the gastrointestinal tissue.

Bottom line

Peripheral blood eosinophilia serves as a systemic marker for gut-driven antigen stimulation and bone marrow activation in gastrointestinal allergic disorders. However, because mucosal recruitment can deplete circulating pools and tissue-level disease can occur independently, a normal peripheral eosinophil count does not rule out active gastrointestinal pathology.

References

  1. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. — pmc.ncbi.nlm.nih.gov ↗
  2. Elements Involved In Promoting Eosinophilic Gastrointestinal Disorders — europepmc.org ↗
  3. Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses. — pmc.ncbi.nlm.nih.gov ↗
  4. Food sensitized pediatric patients show colonic cow's milk protein-specific Th2 cells. — academic.oup.com ↗
  5. Eosinophil trafficking: new answers to old questions — onlinelibrary.wiley.com ↗
  6. Dysregulation of interleukin 5 expression in familial eosinophilia — zenodo.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes low-normal vitamin D weaken immune resilience?→Plausible11 sourcesCan low zinc and low vitamin D constrain immune pathways while an optimal hs-CRP does not support active systemic inflammation?→